Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kevin P. O'Connell is active.

Publication


Featured researches published by Kevin P. O'Connell.


Applied and Environmental Microbiology | 2006

Real-Time Fluorogenic Reverse Transcription-PCR Assays for Detection of Bacteriophage MS2

Kevin P. O'Connell; Jennifer R. Bucher; Patricia E. Anderson; Cheng J. Cao; Akbar S. Khan; Mark V. Gostomski; James J. Valdes

ABSTRACT Bacteriophage MS2 is used in place of pathogenic viruses in a wide variety of studies that range from testing of compounds for disinfecting surfaces to studying environmental transport and fate of pathogenic viruses in groundwater. MS2 is also used as a pathogen simulant in the research, development, and testing (including open air tests) of methods, systems, and devices for the detection of pathogens in both the battlefield and homeland defense settings. PCR is often used as either an integral part of such detection systems or as a reference method to assess the sensitivity and specificity of microbial detection. To facilitate the detection of MS2 by PCR, we describe here a set of real-time fluorogenic reverse transcription-PCR assays. The sensitivity of the assays (performed with primer pairs and corresponding dye-labeled probes) ranged from 0.4 to 40 fg of MS2 genomic RNA (200 to 20,000 genome equivalents). We also demonstrate the usefulness of the primer pairs in assays without dye-labeled probe that included the DNA-binding dye SYBR green. None of the assays gave false-positive results when tested against 400 pg of several non-MS2 nucleic acid targets.


Applied and Environmental Microbiology | 2000

Transcriptional organization and regulation of a polycistronic cold shock operon in Sinorhizobium meliloti RM1021 encoding homologs of the Escherichia coli major cold shock gene cspA and ribosomal protein gene rpsU

Kevin P. O'Connell; Michael F. Thomashow

ABSTRACT A homolog of the major eubacterial cold shock gene cspAwas identified in Sinorhizobium meliloti RM1021 byluxAB reporter transposon mutagenesis. Here we further characterize the organization and regulation of this locus. DNA sequence analysis indicated that the locus includes three open reading frames (ORFs) encoding homologs corresponding to CspA, a novel 10.6-kDa polypeptide designated ORF2, and a homolog of the Escherichia coli ribosomal protein S21. Transcription analysis indicated that this locus produced two different-sized cspA-hybridizing transcripts upon cold shock, a 400-nucleotide (nt) RNA encodingcspA alone and a 1,000-nt transcript encodingcspA-ORF2-rpsU. The sizes of the transcripts agreed with the location of the transcription start site determined by primer extension and the locations of two putative transcriptional terminators. The promoter of the cspA-ORF2-rpsU locus had −10 and −35 elements similar to the E. coliς70 consensus promoter and, like the cspAlocus of E. coli, included an AT-rich region upstream of the −35 hexamer. The promoter of the S. meliloti cspAlocus was found to impart cold shock-induced mRNA accumulation. In addition, the 5′-untranslated region (5′ UTR) was found to increase the fold induction of cspA transcripts after cold shock and depressed the level of luxAB mRNA prior to cold shock, another feature similar to cspA regulation in E. coli. No “cold box” was identified upstream of the S. meliloti cspA gene, however, and there was no other obvious sequence identity between the S. meliloti 5′ UTR and that of E. coli. DNA hybridization analysis indicated that outside the cspA-ORF2-rpsU cold shock locus there are several additional cspA-like genes and a secondrpsU homolog.


Applied and Environmental Microbiology | 2000

Identification of cold shock gene loci in Sinorhizobium meliloti by using a luxAB reporter transposon.

Kevin P. O'Connell; Ann M. Gustafson; M. Deane Lehmann; Michael F. Thomashow

ABSTRACT Using a luxAB reporter transposon, seven mutants ofSinorhizobium meliloti were identified as containing insertions in four cold shock loci. LuxAB activity was strongly induced (25- to 160-fold) after a temperature shift from 30 to 15°C. The transposon and flanking host DNA from each mutant was cloned, and the nucleic acid sequence of the insertion site was determined. Unexpectedly, five of the seven luxAB mutants contained transposon insertions in the 16S and 23S rRNA genes of two of the threerrn operons of S. meliloti. Directed insertion of luxAB genes into each of the three rrnoperons revealed that all three operons were similarly affected by cold shock. Two other insertions were found to be located downstream of a homolog of the major Escherichia coli cold shock gene,cspA. Although the cold shock loci were highly induced in response to a shift to low temperature, none of the insertions resulted in a statistically significant decrease in growth rate at 15°C.


Journal of Immunological Methods | 1999

Assessment of an automated solid phase competitive fluoroimmunoassay for benzoylecgonine in untreated urine

Kevin P. O'Connell; James J. Valdes; Nehad Azer; Robert P. Schwartz; Jeremy Wright; Mohyee E. Eldefrawi

A new solid phase fluoroimmunoassay using a fully automated flow fluorometer adapted for urinalysis of drug metabolites is described. Fluorescein-conjugated benzoylecgonine (FL-BE) and monoclonal antibodies (mAb) against benzoylecgonine (BE) were the reagents used for demonstration. The solid phase consisted of anti-BE mAbs immobilized on the surface of polymethyl methacrylate (PMMA) beads. Free BE in solution competed with FL-BE and reduced bead-bound fluorescence in a concentration-dependent manner. The binding of FL-BE to the anti-BE mAb reached steady-state within minutes. FL-BE was not bound by uncoated beads nor beads coated with non-specific proteins or IgG. The signal-to-noise ratio was 33, and the sensitivity of the assay was 2 ng ml(-1) for BE. The effective concentration of BE was 1 to 100 ng ml(-1), with an IC50 value of 12 ng ml(-1). The mAb showed equal affinities for BE, cocaine, and cocaethylene, but a five order-of-magnitude lower affinity for ecgonine and ecgonine methylester. In a double-blind comparison using clinical urine samples, the data from this single-step competitive assay had excellent agreement with results obtained using a fiber-optic biosensor (FOB), and the EMIT assay performed commercially. The assay provided kinetic data rapidly and can be used to detect small analytes for which antibodies and fluorescein conjugates are available. The affinity of the mAb for FL-BE, calculated from kinetic analysis of the time course of the on and off reaction, was 2.25 x 10(-9) M.


Applied Biochemistry and Biotechnology | 2000

A sensitive solid-phase fluoroimmunoassay for detection of opiates in urine.

Mohyee E. Eldefrawi; Nehad Azer; Nidhi Nath; Nabil A. Anis; M. Bangalore; Kevin P. O'Connell; Robert P. Schwartz; Jeremy Wright

An automated flow fluorometer designed for kinetic binding analysis was adapted to develop a solid-phase competitive fluoroimmunoassay for urinalysis of opiates. The solid phase consisted of polymer beads coated with commercial monoclonal antibodies (MAbs) raised against morphine. Fluorescein-conjugated morphine (FL-MOR) was used as the fluorescein-labeled hapten. The dissociation equilibrium constant (KD) for the binding of FL-MOR to the anti-MOR MAb was 0.23 nM. The binding of FL-MOR to the anti-MOR MAb reached steady state within minutes and was displaced effectively by morphine and other opiates. Morphine-3-glucuronide (M3G), the major urinary metabolite of heroin and morphine, competed effectively with FL-MOR in a concentration-dependent manner for binding to the antimorphine MAb and was therefore used to construct the calibration curve. The sensitivity of the assay was 0.2 ng/mL for M3G. The assay was effective at concentrations of M3G from 0.2 to 50 ng/mL, with an IC50 of 2 ng/mL. Other opiates and heroin metabolites that showed >50% crossreactivity when present at 1 µg/mL included codeine, morphine-6-glucuronide, and oxycodone. Methadone showed very low crossreactivity (<5%), which is a benefit for testing in patients being treated for opiate addictions. The high sensitivity of the assay and the relatively high cutoff value for positive opiate tests allows very small sample volumes (e.g., in saliva or sweat) to be analyzed. A double-blind comparison using 205 clinical urine samples showed good agreement between this single-step competitive assay and a commercially performed enzyme multiplied immunoassay technique for the detection of opiates and benzoylecgonine (a metabolite of cocaine).


Proceedings of the 24th US Army Science Conference | 2006

Native and Engineered Simulants for DNA Virus Threat Agent

Kevin P. O'Connell; Patricia E. Anderson; Michael S. Horsmon; James J. Valdes

Abstract : The ability to test BW detection gear in all stages of development (lab bench, test chamber, and field) and to train using the gear in realistic situations is a cornerstone of biological defense research and operations. Better simulants will allow higher quality and more reproducible testing, as well as more realism in testing and training. There is currently only one virus widely accepted for low-level containment or field release in the study of biological detection, the bacteriophage MS2. While MS2 has been used for decades in the bio-defense research, development, testing, and evaluation communities in lieu of actual viral threat agents, MS2 is less than ideal for several reasons. It is not the same size as most of the recognized threat agents. It does not have the same capsid structure as many viruses of eukaryotes, and the size of the capsid is considerably smaller than many animal viruses. In particular, it is not similar in nearly every respect to any of the orthopoxviruses, a family that includes viral agents of concern. Poxviruses have a virion particle size 20-40 times longer and wider than MS2, has both enveloped and non-enveloped forms (whereas MS2 has only a single virion particle form), and has a doublestranded DNA genome (while the MS2 genome is singlestranded RNA).


Trends in Biotechnology | 1996

Engineering the rhizosphere: Expressing a bias

Kevin P. O'Connell; Robert M. Goodman; Jo Handelsman


Microbiology | 1998

Mutants of Rhizobium tropici strain CIAT899 that do not induce chlorosis in plants

Kevin P. O'Connell; Sandra J. Raffel; Barry J. Saville; Jo Handelsman


Canadian Journal of Microbiology | 2002

Regulation of Sinorhizobium meliloti 1021 rrnA-reporter gene fusions in response to cold shock

Ann M. Gustafson; Kevin P. O'Connell; Michael F. Thomashow


Archive | 2007

Methods for detecting bacteriophage MS2

Kevin P. O'Connell; Akbar S. Khan; Cheng J. Cao; Jennifer R. Bucher; Mark V. Gostomski; James J. Valdes; Patricia E. Anderson

Collaboration


Dive into the Kevin P. O'Connell's collaboration.

Top Co-Authors

Avatar

James J. Valdes

Texas Christian University

View shared research outputs
Top Co-Authors

Avatar

Patricia E. Anderson

Edgewood Chemical Biological Center

View shared research outputs
Top Co-Authors

Avatar

Akbar S. Khan

Edgewood Chemical Biological Center

View shared research outputs
Top Co-Authors

Avatar

Mark V. Gostomski

Science Applications International Corporation

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nehad Azer

University of Maryland

View shared research outputs
Researchain Logo
Decentralizing Knowledge